You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Temodar-Resistant Malignant Glioma

Showing 1 - 25 of 9,889
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Malignant Glioma of Brain Trial in Chicago (Acetazolamide, Temozolomide)

Recruiting
  • Malignant Glioma of Brain
  • Chicago, Illinois
    University of Chicago Medical Center
Apr 1, 2022

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Glioblastoma, Malignant Glioma Trial in Canada, Switzerland, United States (drug, radiation, device)

Completed
  • Glioblastoma
  • Malignant Glioma
  • La Jolla, California
  • +7 more
Apr 13, 2021

Intractable Epilepsy, Malignant Glioma, Seizure Disorder Trial in Jacksonville (Anticonvulsant Agent, Perampanel,

Recruiting
  • Intractable Epilepsy
  • +2 more
  • Anticonvulsant Agent
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Nov 22, 2021

Malignant Glioma, Grade 4 Malignant Glioma, Glioblastoma Trial in Durham (Radiation Therapy, Temozolomide, Bevacizumab)

Completed
Has Results
  • Malignant Glioma
  • +3 more
  • Radiation Therapy
  • +2 more
  • Durham, North Carolina
    Duke Cancer Center
Jan 6, 2021

Ependymoma, Ewing Sarcoma, High-grade Glioma Trial in Worldwide (Nivolumab, NKTR-214)

Completed
  • Ependymoma
  • +9 more
  • Nivolumab
  • NKTR-214
  • Little Rock, Arkansas
  • +17 more
Dec 8, 2022

Malignant Glioma Trial in Rochester (procedure, drug, radiation, other)

Active, not recruiting
Has Results
  • Malignant Glioma
  • Diffusion Weighted Imaging
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic
Jul 15, 2022

Recurrent Malignant Glioma, Brain Glioblastoma Trial in United States (OKN-007, Temozolomide (TMZ))

Recruiting
  • Recurrent Malignant Glioma
  • Brain Glioblastoma
  • Birmingham, Alabama
  • +12 more
Aug 18, 2022

Giant Cell Glioblastoma, Glioblastoma, Gliosarcoma Trial in Rochester (other, biological, drug)

Active, not recruiting
  • Giant Cell Glioblastoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Nov 3, 2021

Glioblastoma, Gliosarcoma Trial in Seattle (radiation, procedure, drug, biological, other)

Completed
Has Results
  • Glioblastoma
  • Gliosarcoma
  • 3-Dimensional Conformal Radiation Therapy
  • +10 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Mar 4, 2022

Glioma, Glioblastoma Trial in Amsterdam (Hydroxyurea, Temozolomide)

Recruiting
  • Glioma
  • Glioblastoma
  • Amsterdam, Noord-Holland, Netherlands
    VU University Medical Center
Oct 6, 2020

Anaplastic Astrocytoma, Glioblastoma, Malignant Glioma Trial in Worldwide (Radiation Therapy, Temozolomide, Veliparib)

Active, not recruiting
  • Anaplastic Astrocytoma
  • +2 more
  • Radiation Therapy
  • +2 more
  • Birmingham, Alabama
  • +162 more
Dec 30, 2022

Chemo-radiation Induced Nausea and Vomiting Trial in Durham (Rolapitant, Ondansetron)

Completed
  • Chemo-radiation Induced Nausea and Vomiting
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Dec 12, 2022

Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Conformal Radiation)

Completed
  • Glioblastoma Multiforme
  • +7 more
  • Aurora, Colorado
  • +4 more
Jun 3, 2020

Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Bevacizumab)

Completed
  • Glioblastoma Multiforme
  • +3 more
  • Castro Valley, California
  • +16 more
May 26, 2020

Brain and CNS Tumors Trial in Chicago, Naperville (arsenic trioxide, temozolomide, radiation therapy)

Unknown status
  • Brain and Central Nervous System Tumors
  • arsenic trioxide
  • +2 more
  • Chicago, Illinois
  • +2 more
Feb 24, 2020

Recurrent High Grade Glioma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma Trial (PCI 24781, Temozolomide)

Not yet recruiting
  • Recurrent High Grade Glioma
  • +4 more
  • (no location specified)
Jan 24, 2023

Glioma, Malignant, High Grade Glioma, Glioblastoma Trial in Tampa (OS2966, Gadoteridol)

Active, not recruiting
  • Glioma, Malignant
  • +4 more
  • Tampa, Florida
    Moffitt Cancer Center
Nov 28, 2022

Glioblastoma Trial in Cincinnati (Modified Atkins Ketogenic Diet)

Active, not recruiting
  • Glioblastoma
  • Modified Atkins Ketogenic Diet
  • Cincinnati, Ohio
    UC Health
Nov 15, 2021

Neuroblastoma Trial (Topotecan, Temozolomide, Ribociclib)

Not yet recruiting
  • Neuroblastoma
  • (no location specified)
Jun 17, 2022

Brain Gliomas Trial in Suzhou (Allogenic B7H3 CAR-?dT cell)

Recruiting
  • Brain Gliomas
  • Allogenic B7H3 CAR-γδT cell
  • Suzhou, Jiangsu, China
    Dushu Lake Hospital Affiliated to Soochow University
Aug 25, 2023

Glioma Trial in Spain, United States (LY2157299, Lomustine)

Active, not recruiting
  • Glioma
  • Baltimore, Maryland
  • +3 more
Oct 18, 2022

Ovarian Aging in Low Grade Glioma Treated With Temozolomide

Terminated
Has Results
  • Low Grade Glioma
    • San Francisco, California
      UCSF Center for Reproductive Health
    Jul 6, 2022

    Glioma, Malignant Trial in Durham (Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine, Hiltonol)

    Not yet recruiting
    • Glioma, Malignant
    • Tumor Associated Antigen Peptide Vaccine P30-EPS Vaccine
    • Hiltonol
    • Durham, North Carolina
      The Preston Robert Tisch Brain Tumor Center at Duke University
    Jan 19, 2023